Abstract
It has been suggested that breastfeeding may prevent inhibitor formation in patients with hemophilia. In a single-center retrospective cohort study, the authors studied the association between breastfeeding and inhibitor development in 90 severe hemophilia A patients born 1975–2003. Mean follow-up was 13.2 years (standard deviation 8.7). A total of 62% of patients received breastfeeding and 20% developed inhibitors. The inhibitor rate according to breastfeeding was similar: 21% in patients who were breastfed and 18% in others. Patients who were breastfed received their first treatment 0.3 years earlier. After adjustment for age at first treatment, we found no protective effect of breastfeeding on inhibitor formation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
